N
This company develops and provides diagnostic and therapeutic technologies for refractory epilepsy. Their patented technology aims to offer effective treatment options for patients who have not responded to other therapies.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- This company develops and provides diagnostic and therapeutic technologies for refractory epilepsy. Their patented technology aims to offer effective treatment options for patients who have not responded to other therapies.